{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:10:08Z","timestamp":1781719808995,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intraneural accumulation of misfolded proteins is a common feature of several neurodegenerative pathologies including Alzheimer\u2019s and Parkinson\u2019s diseases, and Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB). FENIB is a rare disease due to a point mutation in neuroserpin which accelerates protein aggregation in the endoplasmic reticulum (ER). Here we show that cholesterol depletion induced either by prolonged exposure to statins or by inhibiting the sterol reg-ulatory binding-element protein (SREBP) pathway also enhances aggregation of neuroserpin proteins. These findings can be explained considering a computational model of protein aggregation under non-equilibrium conditions, where a decrease in the rate of protein clearance improves aggregation. Decreasing cholesterol in cell membranes affects their biophysical properties, including their ability to form the vesicles needed for protein clearance, as we illustrate by a simple mathematical model. Taken together, these results suggest that cholesterol reduction induces neuroserpin aggregation, even in absence of specific neuroserpin mutations. The new mechanism we uncover could be relevant also for other neurodegenerative diseases associated with protein aggregation.<\/jats:p>","DOI":"10.1038\/srep43669","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T10:03:22Z","timestamp":1488535402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cholesterol impairment contributes to neuroserpin aggregation"],"prefix":"10.1038","volume":"7","author":[{"given":"Costanza","family":"Giampietro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Zapperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina A. M.","family":"La Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"BFsrep43669_CR1","doi-asserted-by":"publisher","first-page":"28283","DOI":"10.1074\/jbc.M313166200","volume":"279","author":"E Miranda","year":"2004","unstructured":"Miranda, E., R\u00f6misch, K. & Lomas, D. A. Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J Biol Chem 279, 28283\u201391 (2004).","journal-title":"J Biol Chem"},{"key":"BFsrep43669_CR2","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/hmg\/ddn041","volume":"17","author":"E Miranda","year":"2008","unstructured":"Miranda, E. et al. The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia fenib. Hum Mol Genet 17, 1527\u201339 (2008).","journal-title":"Hum Mol Genet"},{"key":"BFsrep43669_CR3","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1111\/j.1742-4658.2011.08201.x","volume":"278","author":"BD Roussel","year":"2011","unstructured":"Roussel, B. D. et al. Unravelling the twists and turns of the serpinopathies. FEBS J 278, 3859\u201367 (2011).","journal-title":"FEBS J"},{"key":"BFsrep43669_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1182\/blood.V96.2.569","volume":"96","author":"M Yepes","year":"2000","unstructured":"Yepes, M. et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96, 569\u201376 (2000).","journal-title":"Blood"},{"key":"BFsrep43669_CR5","doi-asserted-by":"publisher","first-page":"17367","DOI":"10.1074\/jbc.M200680200","volume":"277","author":"D Belorgey","year":"2002","unstructured":"Belorgey, D., Crowther, D. C., Mahadeva, R. & Lomas, D. A. Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro . J Biol Chem 277, 17367\u201373 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep43669_CR6","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1111\/j.1432-1033.2004.04270.x","volume":"271","author":"D Belorgey","year":"2004","unstructured":"Belorgey, D. et al. Neuroserpin portland (SER52ARG) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB. Eur J Biochem 271, 3360\u20137 (2004).","journal-title":"Eur J Biochem"},{"key":"BFsrep43669_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/j.1471-4159.2011.07359.x","volume":"118","author":"S Fabbro","year":"2011","unstructured":"Fabbro, S., Schaller, K. & Seeds, N. W. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer\u2019s disease transgenic mouse model. Journal of neurochemistry 118, 928\u2013938 (2011).","journal-title":"Journal of neurochemistry"},{"key":"BFsrep43669_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.neuint.2013.08.010","volume":"63","author":"B Subhadra","year":"2013","unstructured":"Subhadra, B., Schaller, K. & Seeds, N. W. Neuroserpin up-regulation in the Alzheimer\u2019s disease brain is associated with elevated thyroid hormone receptor-\u03b21 and hud expression. Neurochemistry international 63, 476\u2013481 (2013).","journal-title":"Neurochemistry international"},{"key":"BFsrep43669_CR9","doi-asserted-by":"crossref","unstructured":"Lee, T. W., Tsang, V. W. & Birch, N. P. Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous system. Frontiers in cellular neuroscience 9 (2015).","DOI":"10.3389\/fncel.2015.00396"},{"key":"BFsrep43669_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2010.04.005","volume":"1801","author":"L Jones","year":"2010","unstructured":"Jones, L., Harold, D. & Williams, J. Genetic evidence for the involvement of lipid metabolism in Alzheimer\u2019s disease. Biochim Biophys Acta 1801, 754\u201361 (2010).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep43669_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/emmm.201202215","volume":"5","author":"N Pierrot","year":"2013","unstructured":"Pierrot, N. et al. Amyloid precursor protein controls cholesterol turnover needed for neuronal activity. EMBO Mol Med 5, 608\u201325 (2013).","journal-title":"EMBO Mol Med"},{"key":"BFsrep43669_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2164-13-486","volume":"13","author":"J Montag","year":"2012","unstructured":"Montag, J. et al. A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis. BMC Genomics 13, 486 (2012).","journal-title":"BMC Genomics"},{"key":"BFsrep43669_CR13","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1093\/hmg\/ddt310","volume":"22","author":"BD Roussel","year":"2013","unstructured":"Roussel, B. D. et al. Sterol metabolism regulates neuroserpin polymer degradation in the absence of the unfolded protein response in the dementia FENIB. Hum Mol Genet 22, 4616\u201326 (2013).","journal-title":"Hum Mol Genet"},{"key":"BFsrep43669_CR14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/jnr.23278","volume":"91","author":"S Nomura","year":"2013","unstructured":"Nomura, S., Umeda, T., Tomiyama, T. & Mori, H. The E693\u03b4 (Osaka) mutation in amyloid precursor protein potentiates cholesterol-mediated intracellular amyloid \u03b2 toxicity via its impaired cholesterol efflux. J Neurosci Res 91, 1541\u201350 (2013).","journal-title":"J Neurosci Res"},{"key":"BFsrep43669_CR15","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender, K. et al. Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo . Proc Natl Acad Sci USA 98, 5856\u201361 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep43669_CR16","doi-asserted-by":"publisher","first-page":"11302","DOI":"10.1074\/jbc.M801520200","volume":"283","author":"MOW Grimm","year":"2008","unstructured":"Grimm, M. O. W. et al. Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J Biol Chem 283, 11302\u201311 (2008).","journal-title":"J Biol Chem"},{"key":"BFsrep43669_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","volume":"8","author":"LM Refolo","year":"2001","unstructured":"Refolo, L. M. et al. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 8, 890\u20139 (2001).","journal-title":"Neurobiol Dis"},{"key":"BFsrep43669_CR18","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1096\/fj.02-0285fje","volume":"16","author":"Z-X Yao","year":"2002","unstructured":"Yao, Z.-X. & Papadopoulos, V. Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity. FASEB J 16, 1677\u20139 (2002).","journal-title":"FASEB J"},{"key":"BFsrep43669_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.fsigen.2012.05.012","volume":"7","author":"RL Green","year":"2013","unstructured":"Green, R. L., Lagac\u00e9, R. E., Oldroyd, N. J., Hennessy, L. K. & Mulero, J. J. Developmental validation of the AMPSTR NGM select PCR amplification kit: A next-generation str multiplex with the SE33 locus. Forensic Sci Int Genet 7, 41\u201351 (2013).","journal-title":"Forensic Sci Int Genet"},{"key":"BFsrep43669_CR20","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1038\/ncomms4620","volume":"5","author":"Z Budrikis","year":"2014","unstructured":"Budrikis, Z., Costantini, G., La Porta, C. A. M. & Zapperi, S. Protein accumulation in the endoplasmic reticulum as a non-equilibrium phase transition. Nat Commun 5, 3620 (2014).","journal-title":"Nat Commun"},{"key":"BFsrep43669_CR21","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0006-3495(93)81566-2","volume":"64","author":"J Song","year":"1993","unstructured":"Song, J. & Waugh, R. E. Bending rigidity of sopc membranes containing cholesterol. Biophysical journal 64, 1967 (1993).","journal-title":"Biophysical journal"},{"key":"BFsrep43669_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0006-3495(90)82444-9","volume":"58","author":"D Needham","year":"1990","unstructured":"Needham, D. & Nunn, R. S. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophysical journal 58, 997 (1990).","journal-title":"Biophysical journal"},{"key":"BFsrep43669_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cis.2014.03.003","volume":"208","author":"R Dimova","year":"2014","unstructured":"Dimova, R. Recent developments in the field of bending rigidity measurements on membranes. Advances in colloid and interface science 208, 225\u2013234 (2014).","journal-title":"Advances in colloid and interface science"},{"key":"BFsrep43669_CR24","doi-asserted-by":"publisher","first-page":"11694","DOI":"10.1073\/pnas.182412799","volume":"99","author":"PJ Espenshade","year":"2002","unstructured":"Espenshade, P. J., Li, W.-P. & Yabe, D. Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER. Proceedings of the National Academy of Sciences 99, 11694\u201311699 (2002).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFsrep43669_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00249-012-0826-4","volume":"41","author":"CL Armstrong","year":"2012","unstructured":"Armstrong, C. L. et al. Effect of cholesterol on the lateral nanoscale dynamics of fluid membranes. European Biophysics Journal 41, 901\u2013913 (2012).","journal-title":"European Biophysics Journal"},{"key":"BFsrep43669_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1034\/j.1600-0854.2000.011205.x","volume":"1","author":"Y Wang","year":"2000","unstructured":"Wang, Y., Thiele, C. & Huttner, W. B. Cholesterol is required for the formation of regulated and constitutive secretory vesicles from the trans-golgi network. Traffic 1, 952\u2013962 (2000).","journal-title":"Traffic"},{"key":"BFsrep43669_CR27","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.bpj.2009.06.025","volume":"97","author":"J Zhang","year":"2009","unstructured":"Zhang, J., Xue, R., Ong, W.-Y. & Chen, P. Roles of cholesterol in vesicle fusion and motion. Biophys J 97, 1371\u201380 (2009).","journal-title":"Biophys J"},{"key":"BFsrep43669_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1091\/mbc.e05-02-0100","volume":"17","author":"A Ridsdale","year":"2006","unstructured":"Ridsdale, A. et al. Cholesterol is required for efficient endoplasmic reticulum-to-Golgi transport of secretory membrane proteins. Molecular biology of the cell 17, 1593\u20131605 (2006).","journal-title":"Molecular biology of the cell"},{"key":"BFsrep43669_CR29","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1038\/sj.emboj.7601205","volume":"25","author":"H Runz","year":"2006","unstructured":"Runz, H., Miura, K., Weiss, M. & Pepperkok, R. Sterols regulate ER-export dynamics of secretory cargo protein TS-O45-G. EMBO J 25, 2953\u201365 (2006).","journal-title":"EMBO J"},{"key":"BFsrep43669_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ceb.2007.02.004","volume":"19","author":"MT Bengoechea-Alonso","year":"2007","unstructured":"Bengoechea-Alonso, M. T. & Ericsson, J. SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol 19, 215\u201322 (2007).","journal-title":"Curr Opin Cell Biol"},{"key":"BFsrep43669_CR31","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1073\/pnas.0500206102","volume":"102","author":"JD Feramisco","year":"2005","unstructured":"Feramisco, J. D. et al. Intramembrane aspartic acid in SCAP protein governs cholesterol-induced conformational change. Proc Natl Acad Sci USA 102, 3242\u20137 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep43669_CR32","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1073\/pnas.96.20.11041","volume":"96","author":"MS Brown","year":"1999","unstructured":"Brown, M. S. & Goldstein, J. L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96, 11041\u20138 (1999).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep43669_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/sqb.2002.67.491","volume":"67","author":"JD Horton","year":"2002","unstructured":"Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb Symp Quant Biol 67, 491\u20138 (2002).","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"BFsrep43669_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","volume":"124","author":"JL Goldstein","year":"2006","unstructured":"Goldstein, J. L., DeBose-Boyd, R. A. & Brown, M. S. Protein sensors for membrane sterols. Cell 124, 35\u201346 (2006).","journal-title":"Cell"},{"key":"BFsrep43669_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S1461145701002310","volume":"4","author":"LT Friedhoff","year":"2001","unstructured":"Friedhoff, L. T., Cullen, E. I., Geoghagen, N. S. & Buxbaum, J. D. Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (Abeta) peptide. Int J Neuropsychopharmacol 4, 127\u201330 (2001).","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFsrep43669_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1212\/WNL.59.8.1257","volume":"59","author":"K Fassbender","year":"2002","unstructured":"Fassbender, K. et al. Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology 59, 1257\u20138 (2002).","journal-title":"Neurology"},{"key":"BFsrep43669_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/ana.10292","volume":"52","author":"M Simons","year":"2002","unstructured":"Simons, M. et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer\u2019s disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 52, 346\u201350 (2002).","journal-title":"Ann Neurol"},{"key":"BFsrep43669_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/archneur.60.4.510","volume":"60","author":"GL Vega","year":"2003","unstructured":"Vega, G. L. et al. Reduction in levels of 24s-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol 60, 510\u20135 (2003).","journal-title":"Arch Neurol"},{"key":"BFsrep43669_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/153331750401900506","volume":"19","author":"PM Doraiswamy","year":"2004","unstructured":"Doraiswamy, P. M., Steffens, D. C. & McQuoid, D. R. Statin use and hippocampal volumes in elderly subjects at risk for Alzheimer\u2019s disease: a pilot observational study. Am J Alzheimers Dis Other Demen 19, 275\u20138 (2004).","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"BFsrep43669_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","volume":"13","author":"J-J Tang","year":"2011","unstructured":"Tang, J.-J. et al. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab 13, 44\u201356 (2011).","journal-title":"Cell Metab"},{"key":"BFsrep43669_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2125.1995.tb04420.x","volume":"39","author":"J Contermans","year":"1995","unstructured":"Contermans, J., Smit, J. W., B\u00e4r, P. R. & Erkelens, D. W. A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients. Br J Clin Pharmacol 39, 135\u201341 (1995).","journal-title":"Br J Clin Pharmacol"},{"key":"BFsrep43669_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/clc.4960261507","volume":"26","author":"JM McKenney","year":"2003","unstructured":"McKenney, J. M. Pharmacologic characteristics of statins. Clinical cardiology 26, 32\u201338 (2003).","journal-title":"Clinical cardiology"},{"key":"BFsrep43669_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/AAC.5.4.377","volume":"5","author":"J Kotler-Brajtburg","year":"1974","unstructured":"Kotler-Brajtburg, J., Price, H. D., Medoff, G., Schlessinger, D. & Kobayashi, G. S. Molecular basis for the selective toxicity of amphotericin b for yeast and filipin for animal cells. Antimicrob Agents Chemother 5, 377\u201382 (1974).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep43669_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nchembio.387","volume":"6","author":"S Nishimura","year":"2010","unstructured":"Nishimura, S. et al. Marine antifungal theonellamides target 3beta-hydroxysterol to activate RHO1 signaling. Nat Chem Biol 6, 519\u201326 (2010).","journal-title":"Nat Chem Biol"},{"key":"BFsrep43669_CR45","doi-asserted-by":"publisher","first-page":"e83716","DOI":"10.1371\/journal.pone.0083716","volume":"8","author":"S Nishimura","year":"2013","unstructured":"Nishimura, S. et al. Visualization of sterol-rich membrane domains with fluorescently-labeled theonellamides. PLoS One 8, e83716 (2013).","journal-title":"PLoS One"},{"key":"BFsrep43669_CR46","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.chembiol.2015.04.011","volume":"22","author":"Y Arita","year":"2015","unstructured":"Arita, Y. et al. Targeting cholesterol in a liquid-disordered environment by theonellamides modulates cell membrane order and cell shape. Chem Biol 22, 604\u201310 (2015).","journal-title":"Chem Biol"},{"key":"BFsrep43669_CR47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2015.04.010","volume":"36","author":"SM Soyal","year":"2015","unstructured":"Soyal, S. M., Nofziger, C., Dossena, S., Paulmichl, M. & Patsch, W. Targeting SREBPs for treatment of the metabolic syndrome. Trends Pharmacol Sci 36, 406\u201316 (2015).","journal-title":"Trends Pharmacol Sci"},{"key":"BFsrep43669_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20120545","volume":"446","author":"JR Krycer","year":"2012","unstructured":"Krycer, J. R., Phan, L. & Brown, A. J. A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products. Biochem J 446, 191\u2013201 (2012).","journal-title":"Biochem J"},{"key":"BFsrep43669_CR49","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.bcp.2013.02.007","volume":"85","author":"HY Quan","year":"2013","unstructured":"Quan, H. Y. et al. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Biochem Pharmacol 85, 1330\u201340 (2013).","journal-title":"Biochem Pharmacol"},{"key":"BFsrep43669_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/34438","volume":"391","author":"MJ Kuehn","year":"1998","unstructured":"Kuehn, M. J., Herrmann, J. M. & Schekman, R. COPII-cargo interactions direct protein sorting into ER-derived transport vesicles. Nature 391, 187\u201390 (1998).","journal-title":"Nature"},{"key":"BFsrep43669_CR51","doi-asserted-by":"publisher","first-page":"e00951","DOI":"10.7554\/eLife.00951","volume":"2","author":"G Zanetti","year":"2013","unstructured":"Zanetti, G. et al. The structure of the COPII transport-vesicle coat assembled on membranes. eLife 2, e00951 URL https:\/\/dx.doi.org\/10.7554\/eLife.00951 (2013).","journal-title":"eLife"},{"key":"BFsrep43669_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrm2336","volume":"9","author":"E Ikonen","year":"2008","unstructured":"Ikonen, E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 9, 125\u201338 (2008).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep43669_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2006.10.001","volume":"195","author":"DN Kiortsis","year":"2007","unstructured":"Kiortsis, D. N., Filippatos, T. D., Mikhailidis, D. P., Elisaf, M. S. & Liberopoulos, E. N. Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis 195, 7\u201316 (2007).","journal-title":"Atherosclerosis"},{"key":"BFsrep43669_CR54","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm0896-871","volume":"2","author":"JZ Wang","year":"1996","unstructured":"Wang, J. Z., Grundke-Iqbal, I. & Iqbal, K. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in alzheimer\u2019s disease. Nat Med 2, 871\u20135 (1996).","journal-title":"Nat Med"},{"key":"BFsrep43669_CR55","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1111\/febs.13517","volume":"282","author":"C Moriconi","year":"2015","unstructured":"Moriconi, C. et al. Interactions between n-linked glycosylation and polymerisation of neuroserpin within the endoplasmic reticulum. FEBS J 282, 4565\u201379 (2015).","journal-title":"FEBS J"},{"key":"BFsrep43669_CR56","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1021\/acs.analchem.5b04871","volume":"88","author":"H Xiao","year":"2016","unstructured":"Xiao, H., Tang, G. X. & Wu, R. Site-specific quantification of surface n-glycoproteins in statin-treated liver cells. Anal Chem 88, 3324\u201332 (2016).","journal-title":"Anal Chem"},{"key":"BFsrep43669_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0304-4165(98)00127-5","volume":"1426","author":"P Burda","year":"1999","unstructured":"Burda, P. & Aebi, M. The dolichol pathway of n-linked glycosylation. Biochim Biophys Acta 1426, 239\u201357 (1999).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep43669_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1471-4159.2009.05894.x","volume":"109","author":"S Fabbro","year":"2009","unstructured":"Fabbro, S. & Seeds, N. W. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. Journal of neurochemistry 109, 303\u2013315 (2009).","journal-title":"Journal of neurochemistry"},{"key":"BFsrep43669_CR59","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1194\/jlr.M900236-JLR200","volume":"50","author":"W Dong","year":"2009","unstructured":"Dong, W., Vuletic, S. & Albers, J. J. Differential effects of simvastatin and pravastatin on expression of Alzheimer\u2019s disease-related genes in human astrocytes and neuronal cells. J Lipid Res 50, 2095\u2013102 (2009).","journal-title":"J Lipid Res"},{"key":"BFsrep43669_CR60","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nmeth.2075","volume":"9","author":"F de Chaumont","year":"2012","unstructured":"de Chaumont, F. et al. Icy: an open bioimage informatics platform for extended reproducible research. Nat Methods 9, 690\u20136 (2012).","journal-title":"Nat Methods"},{"key":"BFsrep43669_CR61","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0031-3203(01)00127-3","volume":"35","author":"J-C Olivo-Marin","year":"2002","unstructured":"Olivo-Marin, J.-C. Extraction of spots in biological images using multiscale products. Pattern recognition 35, 1989\u20131996 (2002).","journal-title":"Pattern recognition"},{"key":"BFsrep43669_CR62","doi-asserted-by":"publisher","first-page":"e32444","DOI":"10.1371\/journal.pone.0032444","volume":"7","author":"R Noto","year":"2012","unstructured":"Noto, R. et al. The tempered polymerization of human neuroserpin. PLoS One 7, e32444 URL http:\/\/dx.doi.org\/10.1371 (2012).","journal-title":"PLoS One"},{"key":"BFsrep43669_CR63","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0021-9991(76)90041-3","volume":"22","author":"DT Gillespie","year":"1976","unstructured":"Gillespie, D. T. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. Journal of Computational Physics 22, 403\u2013434 URL http:\/\/www.sciencedirect.com\/science\/article\/pii\/0021999176900413 (1976).","journal-title":"Journal of Computational Physics"},{"key":"BFsrep43669_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jcph.1995.1039","volume":"117","author":"S Plimpton","year":"1995","unstructured":"Plimpton, S. Fast parallel algorithms for short-range molecular dynamics. Journal of Computational Physics 117, 1\u201319 URL http:\/\/www.sciencedirect.com\/science\/article\/pii\/S002199918571039X (1995).","journal-title":"Journal of Computational Physics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep43669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep43669","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep43669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:20:59Z","timestamp":1671841259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep43669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,2]]}},"alternative-id":["BFsrep43669"],"URL":"https:\/\/doi.org\/10.1038\/srep43669","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]},"assertion":[{"value":"28 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43669"}}